A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy

NCT04002310 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
18
Enrollment
INDUSTRY
Sponsor class

Stopped The trial was discontinued in the interests of patients considering benefit/risk balance.

Conditions

Interventions

Sponsor

Boehringer Ingelheim